{
    "2018-12-07": [
        [
            {
                "time": "",
                "original_text": "五大机构解读医药股暴跌：带量采购降价超预期",
                "features": {
                    "keywords": [
                        "医药股",
                        "暴跌",
                        "带量采购",
                        "降价",
                        "超预期"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国海: 带量采购推动仿制药变革 创新类公司必配(名单)",
                "features": {
                    "keywords": [
                        "带量采购",
                        "仿制药",
                        "变革",
                        "创新类公司",
                        "名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“带量采购”结果出炉 机构：仿制药格局将重塑",
                "features": {
                    "keywords": [
                        "带量采购",
                        "结果",
                        "仿制药",
                        "格局",
                        "重塑"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股国际化步伐再加速，逾七成MSCI成份股受机构青睐",
                "features": {
                    "keywords": [
                        "A股",
                        "国际化",
                        "MSCI",
                        "成份股",
                        "机构青睐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}